Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium vs Quetiapine in Bipolar Disorder
NCT01526148Phase 4Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2012
- Primary completion
- Jan 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium, quetiapine in bipolar disorder (BD), sponsored by University Hospitals Cleveland Medical Center. Started Jan 2012; status: terminated.
02
Drugs
lithiumquetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT01526148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01526148.